I've never been particularly fond of orthopedic extremity specialist Tornier (TRNX),
but even I wouldn't have expected the wild ride these shares have been
on over the past year. Management's decision to shift its
sales/distribution strategy has introduced a lot of noise into quarterly
earnings and I believe the shares have also gotten caught up in the
sell-off in riskier healthcare names. Tornier's business is still pretty
messy, but the company has a very good shoulder franchise and
extremities could be the next area of consolidation in the device space.
Follow this link for more:
A Step In The Right Direction For Tornier
No comments:
Post a Comment